This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Howard University, Other. Active years: 2016-2023.
Location History:
- Windsor Mill, MD (US) (2016)
- Columbia, MD (US) (2023)
Company Filing History:
1 out of 97 
1 out of 834,411 Years Active: 2016-2023
Title: **Innovative Contributions of Emmanuel S Akinboye in Cancer Treatment**
Introduction
Emmanuel S Akinboye, an inventive mind based in Columbia, MD, has made significant strides in the field of medical research. With two patents to his name, his work focuses primarily on the development of specialized compounds aimed at treating various forms of cancer. His innovative approach towards prodrugs showcases a blend of creativity and scientific rigor that addresses critical health challenges.
Latest Patents
Akinboye's most recent patents revolve around "Emetine derivatives, prodrugs containing same, and methods of treating conditions using same." The compounds he developed are designed to serve as prodrugs that undergo selective activation to release emetine in specific cellular conditions. One of the highlights of these derivatives is their capability to incorporate a blocking group onto the emetine molecule through the derivation of the N2'-position. This modification allows for selective removal by hydrolysis within the cancer or tumor microenvironment. Notably, these compounds exhibit reduced cytotoxicity compared to traditional emetine and remain largely inactive in non-cancerous cells. This remarkable feature makes them suitable for addressing both metastatic and non-metastatic cancers, effectively targeting diseases such as breast cancer, prostate cancer, lung cancer, and leukemia.
Career Highlights
Throughout his career, Akinboye has made noteworthy contributions while working at various research institutions, including Howard University. His innovative projects reflect his commitment to advancing cancer treatment and pharmaceutical research, building upon his educational background and experience within the industry.
Collaborations
Akinboye has collaborated with esteemed colleagues, such as Oladapo Bakare and Samuel Ray Denmeade. These partnerships have fostered a productive exchange of ideas and expertise, paving the way for breakthroughs in medical research and enhancing the development of targeted therapies.
Conclusion
Emmanuel S Akinboye stands out as a prominent inventor in the realm of cancer treatment solutions. His innovative patents not only represent a significant advancement in pharmacological development but also highlight the exciting potential for future applications in the medical field. Through his work, Akinboye continues to inspire fellow researchers and innovators to explore novel approaches for combating complex diseases.